Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study
- PMID: 2089114
- DOI: 10.1007/978-3-7091-9113-2_9
Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study
Abstract
The effect of reversible inhibitors of the monoamine oxidase type A (MAO-A), moclobemide (Aurorix) and Ro 41-1049 (20 mg/kg i.p. each), as well as of reversible inhibitors of the MAO type B (MAO-B), Ro 19-6327 (1 mg/kg i.p.), on the outflow of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) was studied in the rat by transstriatal microdialysis. Reversible MAO-A inhibitors markedly increased the output of DA and concomitantly decreased the output of DOPAC and HVA. These effects were absent with the highly selective MAO-B inhibitor Ro 19-6327.
Similar articles
-
Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.Psychopharmacology (Berl). 1992;106 Suppl:S17-20. doi: 10.1007/BF02246227. Psychopharmacology (Berl). 1992. PMID: 1546133
-
Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.J Neurochem. 1996 Oct;67(4):1532-9. doi: 10.1046/j.1471-4159.1996.67041532.x. J Neurochem. 1996. PMID: 8858937
-
In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.J Neural Transm Park Dis Dement Sect. 1995;10(2-3):79-89. doi: 10.1007/BF02251224. J Neural Transm Park Dis Dement Sect. 1995. PMID: 9620056
-
Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties).Pharmacol Toxicol. 2001 Nov;89(5):217-24. doi: 10.1034/j.1600-0773.2001.d01-151.x. Pharmacol Toxicol. 2001. PMID: 11881974 Review.
-
From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.J Neural Transm Suppl. 1990;29:279-92. doi: 10.1007/978-3-7091-9050-0_27. J Neural Transm Suppl. 1990. PMID: 2193111 Review.
Cited by
-
Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.Br J Pharmacol. 2000 Aug;130(8):1992-8. doi: 10.1038/sj.bjp.0703493. Br J Pharmacol. 2000. PMID: 10952692 Free PMC article.
-
Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.Psychopharmacology (Berl). 1992;106 Suppl:S17-20. doi: 10.1007/BF02246227. Psychopharmacology (Berl). 1992. PMID: 1546133
-
Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.Psychopharmacology (Berl). 2003 May;167(2):211-8. doi: 10.1007/s00213-003-1408-z. Epub 2003 Mar 22. Psychopharmacology (Berl). 2003. PMID: 12652347
-
Quantitative distribution of rat brain monoamine oxidase A by [14C]clorgyline autoradiography.Exp Brain Res. 1994;99(3):375-8. doi: 10.1007/BF00228974. Exp Brain Res. 1994. PMID: 7957717
-
Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.Naunyn Schmiedebergs Arch Pharmacol. 1996 Jun;354(1):17-24. doi: 10.1007/BF00168701. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8832583
MeSH terms
Substances
LinkOut - more resources
Research Materials